XXXX in @entity8 : a comparison of dialysis-related utilization and costs with other chronic kidney diseases.

@entity1 @entity8 @entity454
BACKGROUND: @entity8 ( @entity8 ) is the leading inheritable cause of @entity454 ( @entity454 ) and one of the leading causes of @entity454 overall. @entity8 @entity1 differ from the overall dialysis population; however, there is little published data regarding health care costs for @entity8 @entity1 on dialysis. METHODS: This retrospective observational cohort study was designed to quantify health care utilization and costs for @entity8 @entity1 with @entity454 who received initial services at a single large dialysis organization between January 1, 2007 and December 31, 2009. Parallel results and baseline @entity1 characteristics for control @entity1 with @entity454 etiologies other than @entity8 were performed for reference. Dialysis-related utilization and health care costs for @entity1 with @entity8 in @entity454 overall and during time horizons that correspond to Medicare-eligibility benchmarks were analyzed. Baseline @entity1 characteristics were described for all @entity1 and included demographics, comorbid illnesses, and clinical characteristics. Dialysis-related utilization, hospitalization rates, and health care costs were considered longitudinally. RESULTS: Total health care costs for @entity8 @entity1 were high at US 51,048 per @entity1 -year based on the overall analysis. Total health care costs were lower for @entity8 @entity1 than for control @entity1 on dialysis. @entity1 with @entity8 were generally younger, had a lower Charlson Comorbidity Index, and had lower rates of comorbid conditions, which may have contributed to the lower overall costs seen for @entity1 with @entity8 . CONCLUSION: Health care resource utilization and costs for @entity1 with @entity8 in @entity454 requiring dialysis were high, and therapeutic interventions that can prevent or delay the progression to @entity454 may increase dialysis-free life for @entity1 with @entity8 .
